Company records / kriyatherapeutics.com
Kriya Therapeutics Kriya Therapeutics (kriyatherapeutics.com ): 6 changes recorded in its website history since April 2020. Homepage last checked 6 November 2026.
First recorded website Recorded changes Messaging history Cite this record Report a correction Recorded changes Newest observations first. Each interval bounds when the website changed; it is not an exact event date.
Messaging Between 7 July 2026 and 6 November 2026 Before Gene Therapy. Redefined.
After The Durable Medicines Company
Classifier interpretation of website text.
Funding Between 15 July 2025 and 7 July 2026 Announced on its homepage: “Since our founding in 2019, Kriya has raised over $900 million in investments.”.
Observed on the company’s website; business claims are not independently verified.
Funding Between 9 July 2024 and 15 July 2025 Announced on its homepage: “Since our founding in 2019, Kriya has raised over $600 million in investments.”.
Observed on the company’s website; business claims are not independently verified.
Headline Between 14 July 2022 and 3 July 2023
Before Kriya Therapeutics - Unleashing the Power of Gene Therapy
After Gene Therapy. Redefined.
Observed on the company’s website; business claims are not independently verified.
Investors Between 28 April 2020 and 19 January 2021 Now shows investor logos: QVT Financial LP, Dexcel Pharma, Forsite Capital, Transhuman Capital, BlueBird Ventures, Amplo and JDRF T1D Fund.
Observed on the company’s website; business claims are not independently verified.
Hiring Between 28 April 2020 and 19 January 2021 Added a careers page.
Observed on the company’s website; business claims are not independently verified.
First recorded website Observed 28 April 2020
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself UNLEASHING THE POWER OF GENE THERAPY Our mission at Kriya Therapeutics is to expand the reach of gene therapy to address highly prevalent diseases affecting millions of patients.
archived page Link to first observation
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messaging The Durable Medicines Company Kriya is building durable medicines designed to replace chronic re-treatment with a single administration—therapeutic medicines that can scale to millions.
This wording observed 6 November 2026.
April 2020 – July 2026 · 8 captures Gene Therapy. Redefined. Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
This wording observed 7 July 2026.
Inspect 8 captures in this group 28 April 2020 · UNLEASHING THE POWER OF GENE THERAPY archived page 19 January 2021 · Kriya Therapeutics - Unleashing the power of gene therapy archived page 9 January 2022 · Kriyatx - Unleashing the Power of Gene Therapy archived page 14 July 2022 · Kriya Therapeutics - Unleashing the Power of Gene Therapy archived page 3 July 2023 · Gene Therapy. Redefined. archived page 9 July 2024 · Gene Therapy. Redefined. archived page 15 July 2025 · Gene Therapy. Redefined. archived page 7 July 2026 · Gene Therapy. Redefined. archived page Cite this record StartupHistory, “Kriya Therapeutics” company record, https://startuphistory.org/c/kriyatherapeutics.com
Machine-readable: /c/kriyatherapeutics.com.json . How changes are found: method .